Freeze on drug prices will save NHS £1bn over next two years

Money-saving deal goes through despite opposition from pharmaceutical companies

Health Reporter

The NHS is set to save more than £1bn over the next two years thanks to a deal struck with drug companies to freeze the amount the health service spends on the most expensive drugs.

Branded medicines cost the health service £12bn last year and price rises have seen costs rise by five per cent annually, putting huge demands on stretched NHS budgets.

But under a new five-year deal, which has been staunchly opposed by some drug companies, NHS spending on patented medicines will remain flat for two years, followed by small increases of just under two per cent over the following three years – with drug companies paying back any costs above this level.

The Government hailed the deal as a “breakthrough” which would increase the availability of the best medicines without incurring out-of-control costs to the taxpayer.

But pharmaceutical companies said the move would scare away investment in British medicines research, leading to patients “missing out” on the latest treatments.

The deal, which was negotiated by the Department of Health on behalf of the national health services in England, Scotland, Wales and Northern Ireland, applies to branded medicines – those which are patented to one company and therefore usually the most expensive.

A Department of Health spokesperson said that all money paid back by drug companies would be divided between the four national health services. 

Popular drugs such as GlaxoSmithKline’s asthma treatments Ventolin and Seretide, and Roche’s cancer drug Mabthera, will be covered by the deal.

The agreement comes after many months of negotiating, described by the Association of the British Pharmaceutical Industry (ABPI) as the “most complex” ever held with the British government. It follows crackdowns in other countries on the spiralling costs of drugs, which governments fear are crippling recession-hit healthcare systems.

However, despite agreeing to the payment freeze, the ABPI said that negotiations had been “built on a myth that medicines are expensive in the UK”, arguing that prices were among the lowest in Europe.

The deal is voluntary and drug companies that do not sign up will be hit with a statutory 15 per cent price cut on their medicines. The statutory scheme will impact around 10 per cent of branded medicines used in the UK.

Drug company Pfizer claimed the deal was “damaging… for all those concerned, but most notably for UK patients.”

“This Government price cut alongside the on-going issues in assessing medicines for NHS use sends a clear message that innovation is not truly valued or supported. Whilst the UK Government wants new medicines to be researched and developed here, it is not prepared to pay for the life changing and life-saving medicines that result from this investment. In today’s competitive global economy such a stance sends the wrong signal for potential future decisions,” the company said in a statement.

The health secretary Jeremy Hunt said: “This agreement ensures NHS patients will receive the best and most advanced medicines in the world while managing the cost.

“UK pharmaceutical companies have responded to the challenges we face as a country, both in terms of the increased demand for medicines and pressure on public spending. I hope in return we have given them the certainty and backing they need to flourish as a sector both here and in the global market.”

Life and Style
ebookNow available in paperback
ebooks
ebookA delicious collection of 50 meaty main courses
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
SPONSORED FEATURES

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: Buyer / Planner

    £20000 - £23000 per annum: Recruitment Genius: An excellent opportunity has ar...

    Recruitment Genius: Marketing Manager

    £40000 per annum: Recruitment Genius: This is a fantastic opportunity working ...

    Recruitment Genius: Assistant Journals Manager

    £33000 per annum: Recruitment Genius: The prime focus of the role is to assist...

    SThree: Trainee Recruitment Consultant - Bristol

    £18000 - £23000 per annum + Uncapped OTE: SThree: SThree Trainee Recruitment C...

    Day In a Page

    Giants Club: After wholesale butchery of Idi Amin's regime, Uganda’s giants flourish once again

    Uganda's giants are flourishing once again

    After the wholesale butchery of Idi Amin's regime, elephant populations are finally recovering
    The London: After 350 years, the riddle of Britain's exploding fleet is finally solved

    After 350 years, the riddle of Britain's exploding fleet is finally solved

    Archaeologists will recover a crucial item from the wreck of the London which could help shed more light on what happened in the vessel's final seconds
    Airbus has patented a jet that could fly from London to New York in one hour

    Airbus has patented a jet that could fly from London to New York in one hour

    The invention involves turbojets and ramjets - a type of jet engine - and a rocket motor
    10 best sun creams for kids

    10 best sun creams for kids

    Protect delicate and sensitive skin with products specially formulated for little ones
    Tate Sensorium: New exhibition at Tate Britain invites art lovers to taste, smell and hear art

    Tate Sensorium

    New exhibition at Tate Britain invites art lovers to taste, smell and hear art
    Ashes 2015: Nice guy Steven Finn is making up for lost time – and quickly

    Nice guy Finn is making up for lost time – and quickly

    He was man-of-the-match in the third Test following his recall to the England side
    Ashes 2015: Remember Ashton Agar? The No 11 that nearly toppled England

    Remember Ashton Agar?

    The No 11 that nearly toppled England
    Turkey-Kurdish conflict: Obama's deal with Ankara is a betrayal of Syrian Kurds and may not even weaken Isis

    US betrayal of old ally brings limited reward

    Since the accord, the Turks have only waged war on Kurds while no US bomber has used Incirlik airbase, says Patrick Cockburn
    VIPs gather for opening of second Suez Canal - but doubts linger over security

    'A gift from Egypt to the rest of the world'

    VIPs gather for opening of second Suez Canal - but is it really needed?
    Jeremy Corbyn dresses abysmally. That's a great thing because it's genuine

    Jeremy Corbyn dresses abysmally. That's a great thing because it's genuine

    Fashion editor, Alexander Fury, applauds a man who clearly has more important things on his mind
    The male menopause and intimations of mortality

    Aches, pains and an inkling of mortality

    So the male menopause is real, they say, but what would the Victorians, 'old' at 30, think of that, asks DJ Taylor
    Man Booker Prize 2015: Anna Smaill - How can I possibly be on the list with these writers I have idolised?

    'How can I possibly be on the list with these writers I have idolised?'

    Man Booker Prize nominee Anna Smaill on the rise of Kiwi lit
    Bettany Hughes interview: The historian on how Socrates would have solved Greece's problems

    Bettany Hughes interview

    The historian on how Socrates would have solved Greece's problems
    Art of the state: Pyongyang propaganda posters to be exhibited in China

    Art of the state

    Pyongyang propaganda posters to be exhibited in China
    Mildreds and Vanilla Black have given vegetarian food a makeover in new cookbooks

    Vegetarian food gets a makeover

    Long-time vegetarian Holly Williams tries to recreate some of the inventive recipes in Mildreds and Vanilla Black's new cookbooks